Sponsor:
Aclarion
Code:
NCT06661850
Conditions
Discogenic Low Back Pain
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Fusion or TDR determined by investigator.
Brief summary:
Conditions
Discogenic Low Back Pain
Study ID
NCT06661850
Start date
Jun 11, 2025
Status verified date
Jul, 2026
Completion date
Dec 31, 2027
Anticipated
Primary completion date
Sep 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Arms
Blinded-to-NOCISCAN
Unblinded-to-NOCISCAN
Interventions
Fusion or TDR determined by investigator.
Primary outcome measure
Central contacts
Andy Murillo
amurillo@aclarion.comLocations
Todd H. Lanman, M.D Inc
Recruiting
Beverly Hills, California, United States, 90210
Contacts
Principal Investigator:
Todd Lanman, MD
Scripps Health
Recruiting
La Jolla, California, United States, 92037
Contacts
Principal Investigator:
Hani Malone, MD
USC Keck Medical Center
Recruiting
Los Angeles, California, United States, 90033
Contacts
Principal Investigator:
Patrick Hsieh, MD
University of Miami/ Jackson Health System
Recruiting
Miami, Florida, United States, 33136
Contacts
Principal Investigator:
Gregory Basil, MD
Northwestern University
Recruiting
Chicago, Illinois, United States, 60611
Contacts
Principal Investigator:
Alpesh Patel, MD
Endeavor Health
Recruiting
Evanston, Illinois, United States, 60201
Contacts
Principal Investigator:
Michael Musacchio, MD
Advocate Aurora Research Institute
Recruiting
Park Ridge, Illinois, United States, 60068
Contacts
Principal Investigator:
Patrick Sugrue, MD
Johns Hopkins Medicine
Recruiting
Baltimore, Maryland, United States, 21287
Contacts
Principal Investigator:
Daniel Lubelski, MD
Texas Back Institute
Recruiting
Plano, Texas, United States, 75093
Contacts
Principal Investigator:
Alexander Satin, MD
Sponsor
Aclarion
Last update posted
Jul 24, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-04. This information was provided to ClinicalTrials.gov by Aclarion on 2026-07-24.